How Japan’s Medical Devices Industry is Evolving and Why It Still Cannot Fully Meet Growing Domestic Demand

Japan is home to one of the largest medical device markets in the world. Driven by the world’s most rapidly aging population and increased life expectancy, demand for medical devices across diagnostics, imaging, consumables, and advanced therapeutic technologies continues to expand at a notable pace. Market estimates suggest Japan’s medical device sector reached nearly $40 billion in 2024 and is projected to grow substantially through the rest of this decade, with some forecasts indicating stronger expansion beyond 2030.

A core driver of this growth is Japan’s demographic profile. With a significant proportion of its population aged 65 and over, and life expectancy among the highest globally, demand for healthcare services and supportive technologies constantly increases. This trend naturally stimulates demand for cardiac devices, orthopedic implants, home-care equipment, in-vitro diagnostics, and other MedTech solutions designed for long-term chronic and age-related conditions.

However, Japan’s industry cannot fully satisfy this opportunity with domestic production alone. A mix of structural, economic, and regulatory factors has led to continued dependence on imports for a large share of medical devices used in the country.

High Import Dependence and Domestic Manufacturing Constraints

Despite the size of the market, Japan still relies heavily on foreign-made medical devices. Import ratios for the sector hover around 60 percent or more, especially for advanced diagnostics and treatment systems where foreign manufacturers dominate with cutting-edge technologies.

Several core reasons underpin this reliance:

1. Cost Pressures on Domestic Production
Local manufacturing is challenged by higher raw material costs and labor expenses compared to many other global markets. Japan’s advanced economy offers high wages and stringent safety and quality expectations, increasing the cost of domestically produced MedTech products relative to competitors in lower-cost economies. These input costs can be especially pronounced in specialized components that require precision engineering and high clean-room standards.

2. Regulatory Complexity and Device Approval Timelines
Japan’s regulatory environment, overseen by the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA), is well-established but structured in ways that can extend time to market for innovative devices. Manufacturers must navigate a four-class risk framework and, for higher-risk products, detailed pre-market approval processes that require significant clinical and technical evidence. While foreign clinical data is often accepted, the regulatory process remains a key investment and timing consideration.

Emerging trends in regulatory science, including the use of Real-World Data (RWD) and Real-World Evidence (RWE), are gaining traction as tools to support regulatory decisions and post-market insights in Japan. However, utilization frameworks are still maturing and pose data access and linkage challenges for regulators and industry alike.

3. Scale and Specialization Limitations
Japan excels in some device categories, such as imaging systems and certain high-precision tools. Yet in many product lines, especially consumables, disposables, and modular device components, the country’s production scale is limited relative to global demand. This gap naturally drives import reliance, as overseas manufacturers are better positioned to serve volume-based and cost-sensitive requirements.

Outsourcing and Global Contract Manufacturing Trends

The combination of robust demand, domestic production constraints, and the need for cost-competitive manufacturing is leading to a strategic shift: Japanese MedTech firms are increasingly looking outside their borders for outsourcing and contract manufacturing solutions. Two related trends are particularly noteworthy:

1. Growth of Contract Design and Manufacturing Globally
The contract manufacturing sector for medical devices is expanding rapidly worldwide, with the global market anticipated to grow strongly at double-digit rates into the early 2030s. Japan’s own contract manufacturing segment, which includes specialized device assembly, precision parts, and final product manufacturing, is being outpaced by global industry growth, creating external opportunities for outsourcing partners.

Outsourcing can help Japanese companies reduce production costs, improve time-to-market, and access advanced manufacturing ecosystems that are hard to replicate domestically. This is true not just for low-cost labor but also for production processes requiring scale, digital integration, and flexible supply chain resilience, all critical for MedTech competitiveness.

2. India as a Strategic MedTech Manufacturing Hub
Among emerging global hubs, India is increasingly recognized for its balanced combination of manufacturing capability, cost-efficiency, and innovation potential. India’s medical device ecosystem has seen rapid modernization, supported by government initiatives like “Make in India,” which promote local production hubs, technology adoption, and quality enhancements aligned with international standards.

Strategic partnerships between Japanese companies and Indian manufacturers are not only possibilities but are already taking shape. For example, industry collaborations like Japanese investments in Indian medical device industrial parks, and partnerships supported by organizations like Medical Excellence Japan, underscore mutual commercial interest. Recent industry developments include planned agreements to bring advanced Japanese technology into Indian manufacturing contexts with shared research, training, and export objectives.

India’s manufacturing base also produces globally competitive medical device products and technologies that meet regulatory requirements across established and emerging markets. Indian manufacturers such as Meril Life Sciences have secured regulatory approvals and partnerships in multiple international markets, including agreements with Japanese firms to distribute devices in Japan, illustrating the practical benefits of cross-border cooperation.

Strong India–Japan Economic and Strategic Ties

The broader economic relationship between India and Japan provides fertile ground for deeper MedTech collaboration. These two democracies have steadily strengthened bilateral ties through trade agreements, economic partnerships, and coordinated dialogues on critical sector cooperation, including supply chain security and industrial diversification. Projects like the India-Japan Joint Vision for the Next Decade reflect shared economic goals and complement business strategies across technology and manufacturing sectors.

Organizations such as the Japan External Trade Organization (JETRO) play crucial roles in facilitating this cooperation. Originally focused on exporting Japanese businesses abroad, JETRO’s modern mandate includes promoting bilateral investment flows, supporting foreign companies’ entry into Japan, and enabling partnerships that can enhance supply chain resilience. For Indian and Japanese medical device companies, this means access to market research, partner matchmaking, regulatory insights, and export support that can accelerate mutually beneficial outcomes.

Real-World Evidence and Innovation Opportunities

Innovation remains a core imperative for Japan’s MedTech future. As demand grows for devices that support remote care, chronic disease management, and precision diagnostics, the integration of real-world evidence (RWE) into regulatory decision-making and post-market evaluations is gaining attention. While still evolving, RWE frameworks in Japan could eventually enable faster iteration between clinical performance and commercial scaling, turning real-world outcomes into strategic insights for product development.

Japanese companies that harness RWE generation, incorporate digital health platforms, and partner with global manufacturers to access broader data sources may find competitive advantage in addressing unmet needs across both domestic and international markets.

Japan’s medical device market demand is only set to grow. Tackling supply gaps through strategic outsourcing and international partnerships is not just a short-term solution; it is a forward-looking business strategy that enhances resilience and competitiveness. Together, Japanese innovation and Indian manufacturing expertise can drive new MedTech success stories across global markets.

If you are a Japanese company and are trying to figure out how to cut down manufacturing costs and are unsure where to start, let's talk.